Skip to content

Observational study of dryness of throat

Observational study of dryness of throat - Observational study of dryness of throat

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042415
Enrollment
20
Registered
2020-11-11
Start date
2020-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

None listed

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Healthy Male and females -subjects giving written informed consent.

Exclusion criteria

Exclusion criteria: 1.Those with regularly use cholinergic drugs, anticholinergic drugs (possible dry mouth as one of the side effects) and Kampo that affects dry mouth 2.Subjects who cannot stop ingesting foods that are expected to alleviate dry mouth (throat lozenges and tablet products that have been shown to improve dry mouth) during the test period. 3.Subjects with regularly use first-generation antihistamines (possible dry mouth as one of the side effects) 4.Subjects who cannot stop the actions that significantly affect the dryness of the mouth (stretching the throat and neck, salivary gland massage) from 5 minutes before the evaluation to the end. 5.Subjects who have or are suspected of having a history of Sjogren's syndrome * Sjogren's syndrome is a type of autoimmune disease in which salivary gland secretion is impaired. 6.Subjects with suffer from diseases related to salivary glands such as xerostomia 7.Subjects with undergoing radiation therapy near the oral cavity 8.Subjects with pregnant, those who are willing to become pregnant during the test period, those who are breastfeeding 9.Subjects with suffering from diseases (liver disease, renal disease, diabetes, heart disease, respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergic disease, mental disease, cancer , Infectious diseases, etc.), Those who need continuous hospital visits and follow-up 10.Subjects with judged by the person in charge of testing and research to be unsuitable as participants

Design outcomes

Primary

MeasureTime frame
The amount of saliva secretion

Secondary

MeasureTime frame
Dry throat VAS

Countries

Japan

Contacts

Public ContactMai Umeda

Kao Corporation Biological Science Research

umeda.mai@kao.com+81-3-5630-7268

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026